Education
About Us
Working with TipRanks
Follow Us
Dawnrays Pharmaceutical Holdings Ltd. (HK:2348)
:2348
RESEARCH TOOLSreports
2348 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$1.07 - HK$1.47
Previous CloseN/A
Volume344.00K
Average Volume (3M)4.09M
Market Cap
HK$2.04B
Enterprise ValueHK$659.46M
Total Cash (Recent Filing)HK$1.37B
Total Debt (Recent Filing)¥34.72M
Price to Earnings (P/E)3.3
Beta0.33
Next Earnings
Aug 22, 2025EPS EstimateN/A
Last Dividend Ex-Date
May 27, 2025Dividend Yield5.33%
Share Statistics
EPS (TTM)0.05
Shares Outstanding1,503,061,000
10 Day Avg. Volume851,615
30 Day Avg. Volume4,092,041
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.54
Price to Sales (P/S)0.00
P/FCF Ratio42.25
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Dawnrays Pharmaceutical Holdings Ltd. News
PremiumCompany Announcements
Dawnrays Pharmaceutical Enhances Governance with New Nomination CommitteePremiumCompany Announcements
Dawnrays Pharmaceutical Successfully Passes All AGM Resolutions
PremiumCompany Announcements
Dawnrays Pharmaceutical Announces 2025 AGM and Key Resolutions
PremiumCompany Announcements
Dawnrays Pharmaceutical Declares Special Dividend for 2024
PremiumCompany Announcements
Dawnrays Pharmaceutical Declares Final Dividend for 2024Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
5.26%
Mutual Funds
― Other Institutional Investors
94.74% Public Companies and
Individual Investors
2348 FAQ
What was Dawnrays Pharmaceutical Holdings Ltd.’s price range in the past 12 months?
Dawnrays Pharmaceutical Holdings Ltd. lowest stock price was HK$1.07 and its highest was HK$1.47 in the past 12 months.
What is Dawnrays Pharmaceutical Holdings Ltd.’s market cap?
Dawnrays Pharmaceutical Holdings Ltd.’s market cap is HK$2.04B.
When is Dawnrays Pharmaceutical Holdings Ltd.’s upcoming earnings report date?
Dawnrays Pharmaceutical Holdings Ltd.’s upcoming earnings report date is Aug 22, 2025 which is in 26 days.
How were Dawnrays Pharmaceutical Holdings Ltd.’s earnings last quarter?
Dawnrays Pharmaceutical Holdings Ltd. released its earnings results on Mar 28, 2025. The company reported HK$0.052 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.052.
Is Dawnrays Pharmaceutical Holdings Ltd. overvalued?
According to Wall Street analysts Dawnrays Pharmaceutical Holdings Ltd.’s price is currently Overvalued.
Does Dawnrays Pharmaceutical Holdings Ltd. pay dividends?
Dawnrays Pharmaceutical Holdings Ltd. pays a Notavailable dividend of HK$0.048 which represents an annual dividend yield of 5.33%. See more information on Dawnrays Pharmaceutical Holdings Ltd. dividends here
What is Dawnrays Pharmaceutical Holdings Ltd.’s EPS estimate?
Dawnrays Pharmaceutical Holdings Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Dawnrays Pharmaceutical Holdings Ltd. have?
Dawnrays Pharmaceutical Holdings Ltd. has 1,503,061,000 shares outstanding.
What happened to Dawnrays Pharmaceutical Holdings Ltd.’s price movement after its last earnings report?
Dawnrays Pharmaceutical Holdings Ltd. reported an EPS of HK$0.052 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -2.542%.
Which hedge fund is a major shareholder of Dawnrays Pharmaceutical Holdings Ltd.?
Currently, no hedge funds are holding shares in HK:2348
Dawnrays Pharmaceutical Holdings Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
29.64%
12-Months-Change
Fundamentals
Return on Equity
18.33%
Trailing 12-Months
Asset Growth
6.97%
Trailing 12-Months
Company Description
Dawnrays Pharmaceutical Holdings Ltd.
Dawnrays Pharmaceutical (Holdings) Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally. It operates in two segments, Intermediates and Bulk Medicines, and Finished Drugs. The company offers antibiotics, including pharmaceutical intermediates, bulk medicines, powder for injections, and oral antibiotics. It also provides and system specific medicines comprising cardiovascular systems; anti-allergic, anti-HBV, and digestive systems; urinary systems; and anti-pyretic analgesic, respiratory, and endocrine system drugs in the form of tablets, capsules, and granules. The company was founded in 1995 and is headquartered in Wan Chai, Hong Kong. Dawnrays Pharmaceutical (Holdings) Limited is a subsidiary of Fortune United Group Limited.
Technical Analysis
China Traditional Chinese Medicine Holdings Co
―
Sihuan Pharmaceutical Holdings Group
―
Consun Pharmaceutical Group Ltd.
―
Jacobson Pharma Corporation Limited
―
China Shineway Pharmaceutical Group Limited
―